Cabergoline in the treatment of acromegaly: a study in 64 patients
R Abs, J Verhelst, D Maiter, K Van Acker… - The Journal of …, 1998 - academic.oup.com
Cabergoline is a new, long acting, dopamine agonist that is more effective and better
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
[PDF][PDF] Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients
R ABS, J VERHELST, D MAITER… - J Clin Endocrinol …, 1998 - scholar.archive.org
Cabergoline is a new, long acting, dopamine agonist that is more effective and better
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
Cabergoline in the treatment of acromegaly: a study in 64 patients.
R Abs, J Verhelst, D Maiter, K Van Acker… - Journal of Clinical …, 1998 - orbi.uliege.be
Cabergoline is a new, long acting, dopamine agonist that is more effective and better
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
[PDF][PDF] Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients
R ABS, J VERHELST, D MAITER… - J Clin Endocrinol …, 1998 - researchgate.net
Cabergoline is a new, long acting, dopamine agonist that is more effective and better
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
Cabergoline in the treatment of acromegaly: a study in 64 patients
R Abs, J Verhelst, D Maiter… - The Journal of …, 1998 - pubmed.ncbi.nlm.nih.gov
Cabergoline is a new, long acting, dopamine agonist that is more effective and better
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
Cabergoline in the treatment of acromegaly: a study in 64 patients.
R Abs, J Verhelst, D Maiter, K Van Acker… - The Journal of …, 1998 - europepmc.org
Cabergoline is a new, long acting, dopamine agonist that is more effective and better
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
[PDF][PDF] Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients
R ABS, J VERHELST, D MAITER… - J Clin Endocrinol …, 1998 - academia.edu
Cabergoline is a new, long acting, dopamine agonist that is more effective and better
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
[引用][C] Cabergoline in the treatment of acromegaly: A study in 64 patients
R ABS, J VERHELST, D MAITER… - The Journal of …, 1998 - pascal-francis.inist.fr
Cabergoline in the treatment of acromegaly : A study in 64 patients CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
[引用][C] Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients
R Abs - Journal of Clinical Endocrinology & Metabolism, 1998 - cir.nii.ac.jp
[PDF][PDF] " Cabergoline in the treatment of acromegaly: a study in 64 patients.
R Abs, J Verhelst, D Maiter, K Van Acker… - J Clin Endocrinol …, 1998 - dial.uclouvain.be
Cabergoline is a new, long acting, dopamine agonist that is more effective and better
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …
tolerated than bromocriptine in patients with hyperprolactinemia. Because dopamine …